IMCR7:00 AMImmunocore reports first quarter financial results and provides a business updateimmunocore.com
IMCR6:00 PMKIMMTRAK doubles the likelihood of being alive at five years for first line HLA-A*02:01+ patients with metastatic uveal melanomaPresentation / Abstract • Phase 3immunocore.com
IMCR7:00 AMImmunocore to present at the 25th Annual Needham Virtual Healthcare Conferenceimmunocore.com
IMCR4:30 PMImmunocore will present five-year overall survival data for KIMMTRAK during oral presentation at the 2026 AACR meetingPresentation / Abstract • Phase 3immunocore.com